Aldeyra Therapeutics paid its one named executive on file $1.5M in FY2025 (Dec).
Pay$100 in the stock at the end of FY21 → $88
Pay of each named executive
Todd C. Brady, M.D., Ph.D.President and Chief Executive Officer
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
2 years
Stephen G. Machatha, Ph.D.Chief Development Officer
| FY2025 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
3 years
Michael AlfieriPrincipal Financial Officer and Principal Accounting Officer
| FY2024 (Dec) |
1 year
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.